deCODE genetics, Inc. (Icelandic: Íslensk erfðagreining) is a biopharmaceutical company based in Reykjavík, Iceland. The company was founded in 1996 by Kári Stefánsson to identify human genes associated with common diseases using population studies, and apply the knowledge gained to guide the development of candidate drugs. The company isolated genes believed to be involved in cardiovascular disease, cancer and schizophrenia, among other diseases (the company's research concerning the latter is said to represent the first time a gene has been identified by two independent studies to be associated with schizophrenia).

OPKO Diagnostics LLC engages in the provision of health services. It develops blood testing devices for use in homes and doctors offices. The company was founded by Vincent Linder, George M. Whitesides, David Steinmiller, and Samuel K. Sia in 2004 and is headquartered in Woburn, MA.

Genset Corp., a subsidiary of Merck KGaA, is a company headquartered in San Diego, CA. The firm manufactures and markets pharmaceuticals. It was founded in 1992.

The Jewish General Hospital (JGH; French: Hôpital général juif), known officially as the Sir Mortimer B. Davis Jewish General Hospital (French: Hôpital général juif Sir Mortimer B. Davis) since 1978, is an acute-care teaching hospital in Montreal, Quebec, Canada. Affiliated with McGill University, it has 637 beds.

Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ.

Seoul National University Hospital (서울대학교병원) is one of the oldest and biggest hospitals in South Korea. It is a general and teaching hospital of Seoul National University's College of Medicine. Except SNUH Healthcare System Gangnam Center, all branches have an emergency department (ED).

Serono Genetics Institute SA, a subsidiary of Merck KGaA, is a French company located in Paris. The firm operates a biotechnology company specializing in synthetic DNA and genetic analysis. It was founded in 1989 by Pascal Brandys. Serono Genetics Institute SA was acquired by Serono SA on September 23, 2002 for $65.82 million.

Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden.

Trustees of Dartmouth College, part of Dartmouth College, is a company headquartered in Hanover, NH. The firm operates higher education institutes. It was founded in 1769.

Develops and manufactures drugs for age-related diseases

Diazyme Laboratories is a division of General Atomics headquartered in La Jolla, California. Diazyme uses its enzyme and antibody platform technologies to develop innovative assays for clinical and research uses with reduced costs and improved performance. Products include diagnostic blood tests for cardiovascular disease, diabetes, nutritional assessment, liver disease, renal disease and electrolytes.

In 2008, Takeda Pharmaceutical Company Limited acquired Millennium Pharmaceuticals and the resulting company became exclusively focused on oncology. In 2014, Takeda Oncology was created to become the global headquarters for Takeda’s oncology specialty business unit, in Cambridge, Massachusetts, on the former Millennium Pharmaceuticals site. At Takeda Oncology they endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, they are finding innovative ways to improve the treatment of cancer. They've built a portfolio of paradigm-changing therapies and a leading oncology pipeline. Though They've made great strides in our fight against cancer, they are determined to do more — to work harder and to reach higher. They continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the leaders in oncology that they are today.

AstraZeneca is an innovation-driven biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines that make a meaningful difference in healthcare. AstraZeneca discovers new medicines that are designed to improve the health and quality of life of patients around the world - medicines that are innovative, effective, and which offer added benefits such as reduced side effects or better ways of taking the treatment. AstraZeneca focuses on getting the best from every medicine they make by exploring all the ways it can be used or improved. AstraZeneca was established on April 6, 1999, in Cambridgeshire, United Kingdom.

Urteste SA specializes in the development of technology that allows the detection of cancers at early stages of their development. Its technology helps to detect cancers by measuring the activity of the enzymes in urine and also develops diagnostic tests for more than ten of the most common cancers. The company was founded on April 24, 2019 and is headquartered in Gdansk, Poland.

Andro Diagnostic engages in the development and sale of tests for the detection of prostate cancer.

Arctic Partners Oy Ab is a Finnish private company located in Turku that provides scientific research & development services. The firm was founded in 1990.

Guangzhou Fuda Cancer Hospital is a tertiary specialized cancer hospital which is affiliated with the Health Department of Guangdong Province in China. It was designated a national key clinical (cancer) hospital by the National Health and Family Planning Commission in 2011. The same year, Guangzhou Fuda Cancer Hospital was honored with National Trustworthy Private Hospital by the National Institute of Hospital Administration. In 2012, China Hospital Association rated Guangzhou Fuda Cancer Hospital as China Public Confidence Model Hospital. It was accredited by JCI in 2014.

Shandong Daohuo Gene Technology Co., Ltd., established on 2017-03-13, Business scope includes gene technology,Biotechnology,Technology development of inspection technology,technical consulting,technology transfer,Technology Promotion and Technical Services;Development of biological products,production and sales;Goods import and export business;Technology intermediary service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)